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Chagas disease in patients withHIV infection represents a potentially serious event with high case fatality rates. This study describes
epidemiological and clinical aspects of deaths related to Chagas disease and HIV/AIDS coinfection in Brazil, 1999–2007. We
performed a descriptive study based on mortality data from the nationwide Mortality Information System. Of a total of about
9 million deaths, Chagas disease and HIV/AIDS were mentioned in the same death certificate in 74 cases. AIDS was an underlying
cause in 77.0% (57) and Chagas disease in 17.6% (13). Males (51.4%), white skin color (50%), age group 40–49 years (29.7%), and
residents in the Southeast region (75.7%) were most common. Mean age at death was significantly lower in the coinfected (47.1
years [SD ± 14.6]), as compared to Chagas disease deaths (64.1 years [SD ± 14.7], P < 0.001). Considering the lack of data on
morbidity related to Chagas disease and AIDS coinfection, the use of mortality data may be an appropriate sentinel approach to
monitor the occurrence of this association. Due to the epidemiological transition in Brazil, chronic Chagas disease and HIV/AIDS
coinfection will be further complicated and require the development of evidence-based preventive control measures.
1. Introduction
Chagas disease, caused by the protozoan parasite Try-
panosoma cruzi, is a well-known opportunistic infection
in people living with HIV/AIDS [1–6]. Reactivation of
chronic indeterminate Chagas disease in patients with HIV
infection represents a serious event with high case fatality
rates [1, 3, 4]. New aspects of the immunopathology of
Chagas disease have been described recently in patients
infected with HIV, and unusual clinical manifestations
such as skin lesions, involvement of the central nervous
system (meningoencephalitis), and/or serious heart damage
(myocarditis) related to the reactivation of the disease have
been reported [2–4].
The first case of HIV/T. cruzi coinfection was reported
in the 1980s, but data on several issues are still scanty, such
as the frequency of its occurrence, clinical and laboratorial
profile of subjects with coinfection, survival rates, and
mortality [1, 7, 8].
Chagas disease is endemic in 21 Latin American coun-
tries. Due to migration of Latin Americans, an increasing
public health impact has been observed in nonendemic
countries, such as in Australia, Canada, Japan, Spain, and the
United States [5–7, 9]. Thus, the overlap of HIV infection
and T. cruzi may occur not only in endemic areas, but also
in wealthier regions that receive an increasing number of
potentially infected migrants [1, 6].
Despite the relevance, the clinical importance of this
coinfection and its epidemiology is unknown in Brazil and
other endemic countries [1]. Here, we present an analysis of
deaths related to Chagas disease and HIV/AIDS coinfection
in Brazil, based on multiple causes of death.
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2. Materials and Methods
2.1. Study Design and Population. We performed a descrip-
tive study on population-based nationwide mortality data,
obtained from the Brazilian Mortality Information System
(SIM—Sistema de Informac¸a˜o sobre Mortalidade). SIM data
sets are based on the death certificates (Declarac¸a˜o de o´bito),
consisting of standardized forms to be filled out by the physi-
cians in charge. Death certificates contain demographic data
(age, gender, education, race, marital status, municipality
of residence, and municipality of occurrence of death) and
clinical information (underlying and associated causes of
death).
SIM data are public domain and freely available at
the website of the Informatics Department of Unified
Health System (DATASUS, http://tabnet.datasus.gov.br/cgi/
deftohtm.exe?sim/cnv/obt10uf.def).
We included deaths that occurred in Brazil between
1999 and 2007, in which Chagas disease and AIDS were
mentioned in the same Death Certificate, both as underlying
or associated cause of death (so-called multiple causes of
death).
2.2. Data Processing and Analysis. Downloading of data sets
and data processing has been described in detail previously
[10]. Briefly, a total of 243 mortality data sets with about
9 million entries were downloaded. We obtained the study
population of coinfected individuals by selecting data sets
where Chagas disease and HIV/AIDS were mentioned in any
field of death certificates. Available demographic and clinical
data were used to characterize the study population. We
described frequencies and proportions by gender, age, race,
region of residence, residence and occurrence in state capital,
and year of death.
Chagas disease as a cause of death corresponded to the
category B57 (Chagas disease), including all clinical forms
of the Tenth Revision of the International Statistical Classi-
fication of Diseases and Related Health Problems (ICD-10)
[11]. HIV/AIDS as a cause of death was identified in ICD-10
by the group B20-B24 (disease by human immunodeficiency
virus—HIV) [11].
In addition, we present clinical forms of Chagas disease
and HIV/AIDS that were associated with coinfection. The
description was performed by disease or disorders coded
according to ICD-10. Individual death certificates may have
more than one clinical form of Chagas disease or AIDS.
Data were stored and analysed by STATA version 11
(Stata Corporation, College Station, TX, USA).
2.3. Ethics. This study was solely based on publicly available
secondary anonymous data, with no possibility of identifica-
tion of individuals. Thus, approval by an ethical review board
was not necessary.
3. Results
Between 1999 and 2007, a total of 8,942,217 deaths occurred
in Brazil, with 53,930 (0.6%) deaths related to Chagas
Table 1: Sociodemographic characteristics of deaths related to
Chagas disease and HIV/AIDS co-infection in Brazil, from 1999 to
2007 (n = 74).
Characteristics N %
Sex
Male 38 51.4
Female 36 48.6
Age group (years)
<15 2 2.7
15–29 4 5.4
30–39 18 24.3
40–49 14 18.9
50–59 22 29.7
60–69 11 14.9
≥70 3 4.1
Age at death
<50 38 51.4
≥50 36 48.6
Race/color
Caucasian 37 50.0
Brown 18 24.3
Black 11 14.9
Ignored 8 10.8
Region of residence in Brazil
Southeast 56 75.7
Central West 10 13.5
Northeast 4 5.4
South 4 5.4
Residence in state capital
No 51 68.9
Yes 23 31.1
Death in state capital
Yes 39 52.7
No 35 47.3
disease, and 103,075 (1.1%) related to HIV/AIDS. We
identified 74 deaths in which Chagas disease and HIV/AIDS
were mentioned on the same Death Certificate, either as
underlying or associated causes of death.
Of these coinfected cases, AIDS was an underlying cause
of death in 57 (77.0%), while Chagas disease was listed in
13 (17.6%). Chagas disease and HIV/AIDS were presented
as associated causes in four deaths with other underlying
causes: liver cancer (2), acute myocardial infarction (1), and
skin abscess (1).
Table 1 depicts epidemiological characteristics of deaths
related to Chagas disease and HIV/AIDS coinfection. Males
(51.4%), whites (50%), 40–49 year olds (29.7%), and resi-
dents of the Southeast region (75.7%) were most common.
The mean age at death was significantly lower in the
coinfected (47.1 years [SD± 14.6]), as compared to the total
number of Chagas disease deaths (as published previously
[10]: 64.1 years [SD± 14.7], P < 0.001).
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Table 2: Distribution of deaths related to Chagas disease and HIV/AIDS, according to clinical presentation, Brazil, from 1999 to 2007
(n = 74).
Clinical form (ICD-10) N %
HIV/AIDS∗
HIV disease resulting in other infectious and parasitic diseases (B20.8) 28 37.8
Unspecified human immunodeficiency virus [HIV] disease (B24) 22 29.7
HIV disease resulting in multiple infections (B20.7) 18 24.3
HIV disease resulting in other bacterial infections (B20.1) 3 4.1
HIV disease resulting in multiple diseases classified elsewhere (B22.7) 2 2.7
HIV disease resulting in mycobacterial infection (B20.0) 1 1.4
HIV disease resulting in other specified conditions (B23.8) 1 1.4
Chagas disease∗∗
Chagas disease (chronic) with heart involvement (B57.2) 57 77.0
Acute Chagas disease with heart involvement (B57.0) 6 8.1
Acute Chagas disease without heart involvement (B57.1) 5 6.8
Chagas disease (chronic) with nervous system involvement (B57.4) 5 6.8
Chagas disease (chronic) with digestive system involvement (B57.3) 2 2.7
Chagas disease (chronic) with other organ involvement (B57.5) 1 1.4
∗
In one case two clinical forms were presented.
∗∗In two cases two clinical forms were presented.
Clinical manifestations of HIV/AIDS included other
infectious and parasitic diseases (ICD-10: B20.8) (37.8%)
and unspecified HIV disease (B24) (29.7%; Table 2). In
Chagas disease, the chronic cardiac forms (B57.2) were
predominant (77%; Table 2). Acute Chagas disease with
cardiac involvement (B57.0) (8.1%) and chronic Chagas
disease affecting the nervous system (B57.4) (6.8%; Table 2)
were more common among the HIV-infected as compared to
all deaths by Chagas disease (2.5% and 0.3%, resp.).
4. Discussion
This is the first national population-based analysis of Brazil-
ian mortality data related to Chagas disease and HIV/AIDS
coinfection. In fact, T. cruzi/HIV coinfection has not been
systematically evaluated in themajority of endemic countries
for Chagas disease [7]. The data show an association of
coinfection with early mortality, compared to deaths from
Chagas disease only, as described in a previous study [10].
The magnitude of both AIDS and Chagas disease in Brazil
as chronic conditions will probably increase the likelihood of
occurrence of coinfection in the future [12].
The epidemiology of Chagas disease has changed in
recent decades, with a shift to older age groups, as a
consequence of the control of its main vector (the kissing
bug Triatoma infestans) and the control of transmission
by blood transfusion [1, 10]. The control of these main
means of transmission of Chagas disease may have caused
this observed higher frequency of deaths in the chronic
phase [10, 13]. Our study shows that in contrast to this
trend deaths from coinfection were found predominantly
in young adults. Our observation is consistent with the
epidemiological profile of coinfected subjects described in
previous studies: adult males from endemic regions, with
serological diagnosis in the indeterminate form of the
chronic phase and reactivation of Chagas disease [7].
The lower survival rate of subjects with coinfection is
related to reactivation of Chagas disease and complications
of both diseases [7]. Myocarditis and meningoencephalitis
played also an important role in coinfection deaths as
compared to Chagas disease. This indicates that Chagas
reactivation in the central nervous system andmyocardium is
usually severe, often with fatal results [7]. Reactivation is sus-
pected when the coinfected subject presents clinically acute
Chagas disease or clinical decompensation of the chronic
phase, organic impairment uncommon in Chagas disease,
or pseudotumoral brain lesions [5, 7, 12]. In the case of
absent or controlled reactivation, survival is directly related
to the complications of Chagas disease and of HIV/AIDS
infection. In the case of central nervous system involvement,
delay in diagnosis of Chagas neurological damage and late
introduction of specific therapy against T. cruzi increases case
fatality [3, 8]. However, predictive factors for reactivation of
Chagas disease are not yet fully understood [7, 14].
Reactivation of Chagas disease has been recognized as an
opportunistic disease and was included as an AIDS-defining
event in Brazil in 2003 [15]. Brazil has developed since 2006
a National Network of Attention and Studies in T. cruzi/HIV
coinfection that currently involves cooperation with other
countries, like Argentina and Spain [1].
Overlapping of HIV and T. cruzi infections also occurs in
nonendemic areas of North America and Europe. The imple-
mentation of screening programs for migrant populations is
necessary for early diagnosis of Chagas disease [6, 9].
Due to the lack of systematic data on morbidity related
to Chagas disease and AIDS coinfection, the use of mortality
data may be an appropriate sentinel approach to monitor
the occurrence of this association. Mortality data can be
considered as valid in Brazil, as they are well recorded in
DATASUS database and undergo quality control [16, 17].
Limitations of the study may include problems arising from
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disease notification and data entry [16], and secondary data
may have shown inconsistencies in the quantity and quality
of information [17]. Deaths may be underreported, despite
the progress made during the observation period in terms
of SIM coverage and quality of information on causes of
deaths. The coverage (ratio of deaths reported/estimated)
also presents variations between regions in the country, with
lower coverage mainly in the North and Northeast Regions
[17]. The results of this study show internal consistency and
coherence with existing knowledge about Chagas disease and
HIV/AIDS.
We consider data as highly representative, since all death
certificates during the period 1999 to 2007 were included, in
a country of continental dimensions.
5. Conclusions
The use of multiple causes of death allowed to describe the
magnitude and epidemiological characteristics of mortality
related to Chagas disease and HIV/AIDS coinfection in
Brazil. Due to the ongoing epidemiological transition from
the predominance of infectious diseases to more chronic and
lifestyle-related ones in Brazil, chronic Chagas disease and
HIV/AIDS coinfection require comprehensive and reliable
information that supports the development of preventive
control measures. There is a clear demand for comprehensive
care from primary service providers to reference centers and
to structure a network of comprehensive care to deal with
this situation, with the mobilization that goes from primary
care to highest level of technological complexity.
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